Clinical Microbiology
Quality Assurance
CM-QAQuality assurance in clinical microbiology is the system of checks that lets a laboratory stand behind every organism it names and every susceptibility it releases. It covers external proficiency challenges, daily monitoring for error, verification of new media and instruments, stain quality control, and the document control that keeps everyone working from the same current procedure. At the bench it shows up as small, repeated, recorded actions rather than occasional audits. Quality Assurance is one of the eight competency areas assessed in the Clinical Microbiology Fields-of-Practice examination set by CAMLPR.
Working up external proficiency challenges
External quality assessment sends a laboratory unknown specimens that must be worked up exactly as a patient specimen would be. The point is to measure the whole system — media, staff, instruments, judgement — so the challenges go through the normal bench rotation, on the normal schedule, with no extra replicates and no telephone calls to neighbouring laboratories. Results are submitted by the deadline and the graded report is reviewed when it returns. Any challenge graded unacceptable triggers a documented investigation, a corrective action, and a check on whether patient results from that period were affected.
A microbiology laboratory receives five simulated respiratory specimens from its external proficiency testing provider. A junior technologist asks the charge technologist how the specimens should be handled. What is the appropriate instruction?
A laboratory's proficiency testing report shows an unacceptable grade for one bacterial identification challenge, while the remaining challenges in the survey were graded acceptable. What must the laboratory do next?
Telling random error apart from systematic error
Errors come in two shapes and they are managed differently. Random error scatters results unpredictably in both directions and usually traces to technique variation — inconsistent reading times, pipetting, uneven incubation. Systematic error pushes results consistently one way and usually traces to something that changed: a new reagent lot, a drifting incubator, a recalibrated reader. Plotting control data on a Levey-Jennings chart makes the difference visible, because a shift or a trend looks nothing like scatter. The technologist's job is to notice the pattern early, hold reporting if the run is compromised, find the cause, and record what was done.
A technologist plots the daily cefoxitin zone diameter for the Staphylococcus aureus ATCC 25923 susceptibility control. Days 1 to 6 scatter closely around the mean. From day 7 onward every point sits between +1.8 and +2.2 SD, coinciding with the first use of a new lot of Mueller-Hinton agar. Which description best fits the pattern in [CHART]?
Over two weeks the positive control for a laboratory's nitrocefin beta-lactamase test behaves erratically: a weak colour change on one day, a strong reaction the next day, another weak reaction the following week, with no consistent direction and no change of reagent lot. Which explanation best fits this pattern?
Verifying new media, reagents and instruments before use
Nothing new goes into patient testing on the manufacturer's word alone. Each new lot of media, stain, reagent or identification card is checked against the lot already in use with organisms of known reaction, and the parallel results are recorded before the new lot is released. Media are also examined for sterility, moisture, thickness and pH. New or replacement instruments need a documented verification that they perform as claimed in this laboratory, with this workload and these staff — installation by the vendor is not verification. All of it is retained as evidence, not merely performed.
A shipment containing a new lot of MacConkey agar arrives in the media room. Before the plates are released for patient testing, what does lot-to-lot verification require the technologist to do?
A microbiology laboratory installs a replacement continuous-monitoring blood culture instrument from a different manufacturer than the one it retired. What must be completed before patient bottles are loaded and their results reported?
Judging stain quality before a slide is read
A stain that is read without first being judged is a guess. Every batch of Gram, acid-fast, fluorochrome and fungal stains is run with control smears containing organisms of known staining behaviour, and the control is read before any patient slide. The technologist checks that positives hold their colour, that negatives take up the counterstain, that the background is clean and that the smear is neither too thick nor washed away. When a control fails — most often over-decolourisation turning Gram-positive cocci pink — the patient smears from that batch are not reported. They are stained again and the failure is recorded.
A technologist stains the daily Gram stain control smear alongside fourteen patient smears in the same batch. The Gram-positive control organism appears pink-red rather than purple. What is the correct next step for the patient smears from that batch?
Working from controlled, current procedure documents
Every technologist must be working from the same current version of a procedure. Controlled documents carry an identifier, a version number, an effective date and evidence of who approved them, and only the copy issued through that system may be followed at the bench. Superseded versions are withdrawn and archived so they cannot be picked up by mistake, and informal photocopies taped to shelves have no standing at all. When a procedure changes, staff are trained and their review is recorded before the new version takes effect. Retention periods for withdrawn versions are set by the laboratory's quality manual.
While setting up a stool culture, a technologist finds a photocopied procedure sheet taped inside a cupboard door. It specifies an incubation time that differs from the current controlled manual. What should the technologist do?
A microbiology procedure for antimicrobial susceptibility reporting has been rewritten to reflect updated breakpoints. Which condition must be met before bench staff begin working from the rewritten version?
Back to all clinical microbiology areas in the Clinical Microbiology study guide.
MLTPrep is an independent study resource. Not affiliated with or endorsed by CAMLPR. Always confirm current requirements with CAMLPR directly.